Balaxi Pharmaceuticals Financials
NSE: BALAXI
₹23.34
₹-0.90
(-3.71%)
As on 08-Sep-2026 15:31IST
Market cap
₹135 Cr
Revenue (TTM)
₹280 Cr
P/E Ratio
55.5
P/B Ratio
0.5
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
280.11
|
270.17
|
292.56
|
241.29
|
336.43
|
279.39
|
|
|
|
|
|
|
Total Income
|
283.72
|
272.99
|
294.92
|
241.93
|
339.07
|
284.36
|
|
|
|
|
|
|
Total Expenditure
|
271.07
|
260.59
|
260.35
|
196.75
|
279.02
|
228.56
|
|
|
|
|
|
|
EBITDA
|
9.04
|
9.58
|
32.22
|
44.54
|
57.41
|
50.82
|
|
|
|
|
|
|
Depreciation
|
2.54
|
2.15
|
1.89
|
2.10
|
1.75
|
0.51
|
|
|
|
|
|
|
EBIT
|
6.50
|
7.43
|
30.32
|
42.44
|
55.66
|
50.31
|
|
|
|
|
|
|
Interest
|
3.63
|
4.96
|
4.01
|
2.77
|
1.38
|
0.76
|
|
|
|
|
|
|
Other Income
|
3.61
|
2.82
|
2.36
|
0.63
|
2.64
|
4.97
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
-38.29
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
6.48
|
5.29
|
28.67
|
2.02
|
56.92
|
54.52
|
|
|
|
|
|
|
Provision for Tax
|
4.06
|
3.88
|
3.60
|
4.40
|
10.96
|
6.86
|
|
|
|
|
|
|
Profit after Tax
|
2.42
|
1.42
|
25.07
|
-2.39
|
45.96
|
47.66
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
2.42
|
17.34
|
27.67
|
-7.31
|
51.74
|
48.18
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
249.08
|
249.08
|
231.74
|
201.36
|
182.88
|
113.16
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
25.80
|
25.80
|
24.07
|
2.78
|
3.66
|
0.04
|
|
|
|
|
|
|
Current Liabilities
|
62.16
|
62.16
|
54.53
|
54.20
|
53.13
|
63.27
|
|
|
|
|
|
|
Total Liabilities
|
337.03
|
337.03
|
310.34
|
258.34
|
239.67
|
176.47
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
81.68
|
85.60
|
67.58
|
48.17
|
46.16
|
35.47
|
|
|
|
|
|
|
Current Assets
|
251.43
|
251.43
|
242.77
|
210.17
|
193.51
|
141.00
|
|
|
|
|
|
|
Total Assets
|
337.03
|
337.03
|
310.34
|
258.34
|
239.67
|
176.47
|
|
|
|
|
|
|
Total Debt*
|
--
|
55.79
|
51.62
|
17.66
|
11.62
|
3.64
|
|
|
|
|
|
|
Net Current Assets
|
189.27
|
189.27
|
188.23
|
155.97
|
140.38
|
77.74
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-4.50
|
-35.00
|
4.87
|
6.08
|
34.14
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-20.78
|
-21.76
|
-1.05
|
-10.57
|
-28.45
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
0.44
|
33.88
|
30.25
|
25.51
|
-0.16
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-24.84
|
-22.89
|
34.07
|
21.02
|
5.53
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
0.44
|
3.14
|
5.01
|
-1.34
|
10.16
|
9.64
|
|
|
|
|
|
|
Cash EPS (₹)
|
0.44
|
0.65
|
4.88
|
-0.05
|
9.37
|
9.63
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
45.35
|
45.12
|
41.98
|
36.26
|
33.90
|
22.63
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
0.10
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
-0.82
|
-6.34
|
4.47
|
5.97
|
34.14
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-12.02
|
-7.78
|
8.09
|
-11.58
|
5.43
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
3.48
|
13.01
|
2.31
|
37.46
|
59.62
|
|
|
|
|
|
|
ROE (%)
|
0.99
|
0.59
|
11.68
|
-1.29
|
32.17
|
53.50
|
|
|
|
|
|
|
ROA (%)
|
0.75
|
0.44
|
8.82
|
-0.96
|
22.09
|
34.52
|
|
|
|
|
|
|
EBIT Margin (%)
|
2.32
|
2.75
|
10.36
|
17.59
|
16.54
|
18.01
|
|
|
|
|
|
|
Net Margin (%)
|
0.85
|
0.52
|
8.50
|
-0.99
|
13.56
|
16.76
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
1.32
|
9.22
|
-0.12
|
14.18
|
17.24
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-5.90
|
-7.65
|
21.25
|
-28.28
|
20.42
|
20.77
|
|
|
|
|
|
|
EBIT Growth (%)
|
-77.90
|
-75.50
|
-28.56
|
-23.75
|
10.64
|
18.71
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-87.18
|
-94.35
|
1,150.28
|
-105.19
|
-3.56
|
24.96
|
|
|
|
|
|
|
EPS Growth (%)
|
-87.16
|
-37.33
|
473.78
|
-113.19
|
5.48
|
29.41
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
7.48
|
17.28
|
14.49
|
52.51
|
74.15
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
55.55
|
4.99
|
12.75
|
--
|
2.09
|
7.30
|
|
|
|
|
|
|
Price / Book Value
|
0.54
|
0.35
|
1.52
|
2.74
|
3.13
|
3.11
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
0.14
|
|
|
|
|
|
|
EV/EBITDA
|
13.91
|
10.30
|
10.56
|
10.98
|
8.72
|
6.24
|
|
|
|
|
|
|
Close Price (₹)
|
23.91
|
15.67
|
63.92
|
99.19
|
106.07
|
70.32
|
|
|
|
|
|
|
High Price (₹)
|
52.50
|
73.70
|
151.45
|
137.26
|
141.20
|
149.40
|
|
|
|
|
|
|
Low Price (₹)
|
15.20
|
15.20
|
50.42
|
79.99
|
60.71
|
68.33
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
134.65
|
86.51
|
352.89
|
540.48
|
539.97
|
351.61
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.09
|
0.22
|
0.22
|
0.09
|
0.07
|
0.03
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.13
|
0.13
|
0.09
|
0.06
|
0.03
|
|
|
|
|
|
|
Current Ratio
|
4.05
|
4.05
|
4.45
|
3.88
|
3.64
|
2.23
|
|
|
|
|
|
|
Quick Ratio
|
2.70
|
2.70
|
3.01
|
2.36
|
1.67
|
0.67
|
|
|
|
|
|
|
Interest Coverage
|
2.78
|
2.07
|
8.15
|
1.73
|
42.34
|
72.69
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
48.59
|
50.38
|
37.87
|
23.09
|
15.54
|
9.86
|
|
|
|
|
|
|
Asset Turnover
|
0.87
|
0.83
|
1.03
|
0.97
|
1.62
|
2.02
|
|
|
|
|
|
|
Receivable days
|
--
|
166.78
|
103.86
|
81.67
|
43.31
|
68.14
|
|
|
|
|
|
|
Inventory Days
|
--
|
109.40
|
100.21
|
141.58
|
110.51
|
73.37
|
|
|
|
|
|
|
Payable days
|
--
|
45.22
|
49.80
|
90.14
|
75.41
|
69.04
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
230.96
|
154.28
|
133.11
|
78.42
|
72.47
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
